India Intravenous Solutions Market Share, Size, Trends, Growth, Forecast: By Type: Partial Parenteral Nutrition, Total Parenteral Nutrition; By Nutrient: Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids, Others; Regional Analysis; Market Dynamics; Competitive Landscape; Key Trends and Developments in the Market; 2023-2028

India Intravenous Solutions Market Outlook

The India intravenous solutions market is expected to grow at a CAGR of 5.80% between 2023 and 2028. Major market drivers include fast response rate, higher efficacy, and versatile applications.

Key Trends in the Market

Intravenous solutions, also known as intravenous fluids, are formulated liquids that are given intravenously by injecting into the person’s vein to maintain or restore normal fluid balance and nutrient levels. The intravenous solutions contain various nutrients. The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic. Hypotonic has lower concentration of sugar, fluids, and salts in comparison to blood whereas hypertonic solutions have higher concentrations of these components as compared to blood. Isotonic has equal concentration of fluid, salts, and sugar in comparison to blood.

• Wide prevalence of malnutrition in infants, women, and children has increased the demand for nutritious intravenous solutions that can fulfil the nutritional requirement of the body. This in turn is helping in the growth of the market.

• Increasing cases of cancer are also contributing to the growth of the market for intravenous solutions in India. Radiation and chemotherapy procedures in cancer treatment cause dehydration increasing the demand for fluid in the body which is then met by injecting intravenous fluids.

• The development of the healthcare infrastructure in the country is a key trend supporting the growth of the India intravenous solutions market. With more hospitals and medical care centres available across the country, including in smaller towns, the demand for intravenous solutions is expected to rise. This can be attributed to the versatility of intravenous solutions and their applications in conditions where the patient has inadequate absorption of nutrients and fluids.

Market Analysis

Based on type, the India intravenous solutions market can be bifurcated into partial parenteral nutrition and total parenteral nutrition. By nutrients, the market is divided into carbohydrates, salts and electrolytes, minerals, vitamins, minerals, and amino acids, among others. By region, the market is segmented into North India, West and Central India, South India, and East India.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the India intravenous solutions market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

• Eurolife Healthcare Pvt. Ltd.

• Claris Lifesciences Ltd.

• Nymak Pharma Ltd.

• Amanta Healthcare Limited

• Schwitz Biotech

• Parenteral Drugs (India) Limited

• Soxa Formulations & Research (Pvt.) Ltd

• Kritikos Care

• Others

Market Share by Type

Total parenteral nutrition segment is expected to account for a larger share in the India intravenous solutions market as it is widely used by healthcare providers due to the safety it provides in administration. Providing complete nutritional requirements intravenously, total parenteral nutrition has higher concentration of nutrients and is typically administered through larger veins. As the IV is connected into larger veins, there is lower risk of infection.

Partial parenteral nutrition provides a part of daily nutritional requirements and is used as a supplement for patients that have other nutrition sources. Due to its versatile applications for various conditions the demand is expected to rise. However, partial parenteral nutrition is typically administered via catheter insertion into smaller veins, increasing the risk of infection.

Market Share by Nutrient

Salts and electrolytes are leading segment of the India intravenous solutions market due to their role in combating dehydration and increasing cases of malnutrition. Inadequate nutrition can cause deficiency of minerals, fatigue, reduced immunity, and weak bones in the individual. Salts and electrolytes are used for the regulation of muscle and nerve function, body hydration and to rebuild any damaged tissues.

Amino acids in combination with dextrose, vitamins and other elements are given in the form of dietary supplements to boost protein and calorie intake. They are often used post-surgery or after certain illnesses to provide missing nutrients and meet the metabolic protein requirements of patients.

Competitive Landscape

Eurolife Healthcare Pvt. Ltd. is a pharmaceutical company that manufactures and distributes intravenous infusions, injections, capsules, ointments, creams, ophthalmic products, formulations, tablets, and nebules to its customers globally. It has its headquarter in Mumbai in Maharashtra and was founded in 2001. With their world class quality and competitive rate, they have successfully been accepted in every place they have marketed.

Nymak Pharma Ltd. was established in 1998 and is headquartered in Gandhidham, Gujarat. It is a public company involved in the machinery and equipment manufacturing sector. It manufactures and exports quality products including sterile water for injections, IV fluids, cough syrup, surgical sutures, syringes with needles, ringer lactate, ORS water, and paracetamol IV, among others.

Amanta Healthcare Limited was founded in 1988 and is based in Ahmedabad, Gujarat. It is a pharmaceutical manufacturing company that provides a range of products for domestic markets and international markets. Some of the products provided include electrolyte replacements, diuretics, anti-fungal solutions, common solutions, anti-biotic solutions, and anti-infective solutions, among others.

Other market players include Claris Lifesciences Ltd., Schwitz Biotech, Parenteral Drugs (India) Limited, Soxa Formulations & Research (Pvt.) Ltd, and Kritikos Care, among others.

Key Highlights of the Report

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.